Gadofosveset-enhanced magnetic resonance angiography
Mathias GoyenUniversity Medical Center Hamburg- Eppendorf, Hamburg, GermanyAbstract: Gadofosveset (Vasovist®, Bayer Schering Pharma AG, Berlin/Germany) is the first intravascular contrast agent approved for use with magnetic resonance angiography in the European Union, Switzerland, Turkey, C...
| Published in: | Vascular Health and Risk Management |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-02-01
|
| Online Access: | https://www.dovepress.com/gadofosveset-enhanced-magnetic-resonance-angiography-peer-reviewed-article-VHRM |